华熙生物 (688363) 财务报表

截止日期2022-09-302022-06-302022-03-312021-12-312021-09-30
营业总收入(万元)432037.32293545.22125485.63494777.38301223.32
营业收入(万元)432037.32293545.22125485.63494777.38301223.32
营业总成本(万元)357087.15240973.02102328.17416593.77249914.75
营业成本(万元)98381.5566248.2328695.82108525.2366893.89
净利润(万元)66715.8746692.0719764.5577555.6055385.60
归属于母公司的净利润(万元)67744.0047322.5219975.0978233.4655530.21
营业利润(万元)82253.3958003.5324193.5090555.3364735.11
利润总额(万元)81938.5257637.8824200.2489019.9264495.97
少数股东损益(万元)-1028.13-630.45-210.53-677.85-144.61
基本每股收益(元)1.41(元)0.98(元)0.42(元)1.63(元)1.16(元)
稀释每股收益(元)1.41(元)0.98(元)0.42(元)1.62(元)1.15(元)
非经常性损益(万元)7640.506028.011686.4011899.8510847.77
扣除非经常性损益后净利润(万元)60103.5041294.5118288.6866333.6044682.44
总资产(万元)790633.19783154.53741432.53750374.02664996.94
总负债(万元)161240.16176349.30140251.92180128.03119330.92
归属于母公司股东权益合计(万元)629813.91607120.44601263.02569901.24545121.64
股东权益合计(万元)629393.03606805.23601180.60570245.99545666.03
实收资本(股本)(万元)48108.5348108.5348108.5348000.0048000.00
资本公积(万元)373387.93370952.38368661.33356914.50353756.45
未分配利润(万元)186167.38165745.90161971.65141996.56129270.77
经营活动产生的现金流量净额(万元)11648.6923950.35-21716.99127605.9657303.90
经营活动现金流入小计(万元)481670.20336890.62142466.39551749.62349210.91
经营活动现金流出小计(万元)470021.51312940.27164183.38424143.66291907.00
投资活动产生的现金流量净额(万元)-81192.29-26134.4918187.48-98986.45-70057.27
投资活动现金流入小计(万元)251482.16166592.0378085.26507238.99462375.04
投资活动现金流出小计(万元)332674.46192726.5259897.78606225.43532432.32
筹资活动产生的现金流量净额(万元)-16250.74-14910.103499.01-7135.59-6307.64
筹资活动现金流入小计(万元)22770.2322440.678470.6618397.9118090.91
筹资活动现金流出小计(万元)39020.9737350.774971.6525533.4924398.55
期末现金及现金等价物余额(万元)74800.62143191.33157931.85158492.97119115.78
最后修改日期2022-10-292022-08-302022-04-252022-03-112021-11-13